2/26
12:16 pm
harp
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its "neutral" rating re-affirmed by analysts at Citigroup Inc.. They now have a $23.00 price target on the stock, up previously from $13.00.
Low
Report
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its "neutral" rating re-affirmed by analysts at Citigroup Inc.. They now have a $23.00 price target on the stock, up previously from $13.00.
2/26
11:47 am
harp
Rating for HARP
Low
Report
Rating for HARP
2/26
11:47 am
harp
Rating for HARP
Low
Report
Rating for HARP
1/8
02:17 pm
harp
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock, up previously from $12.00.
Low
Report
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock, up previously from $12.00.
1/8
12:46 pm
harp
Harpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Harpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1/8
12:46 pm
harp
Harpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Low
Report
Harpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1/5
08:02 am
harp
Harpoon Therapeutics, Inc. (NASDAQ: HARP) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $23.00 price target on the stock.
Medium
Report
Harpoon Therapeutics, Inc. (NASDAQ: HARP) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $23.00 price target on the stock.
1/5
07:20 am
harp
Rating for HARP
Medium
Report
Rating for HARP
1/5
07:20 am
harp
Rating for HARP
Medium
Report
Rating for HARP